In line with its essential role, ATP1A3 expression in PBL was found downregulated in PD monkeys in our current study (Fig. 9, pathway 2), suggesting that its PBL expression could be a potential biomarker for non-invasive PD diagnosis. This evidence concerns the gene ATP1A3 and Parkinson disease.